Identification and immunogenicity study of soluble protein derived from pasteurella multocida serotype B / Noor Masyitah Jumahat

Pasteurella multocida (P. multocida) serotype B is associated with hemorrhagic septicaemia (HS) disease endemic in Africa, India and Asian countries. It is causative agent of thriftily significant disease in livestock. Hence, this study purposed and aimed to identify and express an immunogenic solub...

Full description

Bibliographic Details
Main Author: Jumahat, Noor Masyitah
Format: Thesis
Language:English
Published: 2015
Subjects:
Online Access:http://ir.uitm.edu.my/id/eprint/27214/
http://ir.uitm.edu.my/id/eprint/27214/1/TM_NOOR%20MASYITAH%20JUMAHAT%20MD%2015_5.pdf
id uitm-27214
recordtype eprints
spelling uitm-272142020-01-14T02:07:13Z http://ir.uitm.edu.my/id/eprint/27214/ Identification and immunogenicity study of soluble protein derived from pasteurella multocida serotype B / Noor Masyitah Jumahat Jumahat, Noor Masyitah RM Therapeutics. Pharmacology Immunotherapy. Serotherapy Pasteurella multocida (P. multocida) serotype B is associated with hemorrhagic septicaemia (HS) disease endemic in Africa, India and Asian countries. It is causative agent of thriftily significant disease in livestock. Hence, this study purposed and aimed to identify and express an immunogenic soluble protein of P. multocida in efforts toward development of HS vaccine. Immunogenic soluble protein was identified as lipoprotein B (plpB) using electrospray mass spectrometry. The size of expressed purified recombinant protein was approximately 39kDa. Immunogenicity study of the recombinant protein plpB was carried out using 6 groups o f BALB/c mice. The groups were immunized with recombinant protein (Group 1), soluble recombinant protein (Group 2), insoluble recombinant protein (Group 3), vector (Group 4), soluble protein o f P. multocida (Group 5) and PBS (Group 6 ) respectively. Mice in group 4 and 6 showed signs and symptom of HS after challenge with the parental strain (p-value < 0.05). However, immunised mice with purified recombinant protein did not show signs and symptoms of HS. Based on immunoblotting analysis, purified recombinant protein was significantly immunogenic (p-value < 0.05). Additionally, no inflammation was seen in the tissues o f organs from mice immunized with purified recombinant protein, which indicates that recombinant protein was 100% protective towards P. multocida infection and eventually towards HS disease. Thus, this study shows that the recombinant protein lipoprotein B (plpB) is significantly immunogenic and could be a potential candidate in developing vaccine against HS. 2015-04 Thesis NonPeerReviewed text en http://ir.uitm.edu.my/id/eprint/27214/1/TM_NOOR%20MASYITAH%20JUMAHAT%20MD%2015_5.pdf Jumahat, Noor Masyitah (2015) Identification and immunogenicity study of soluble protein derived from pasteurella multocida serotype B / Noor Masyitah Jumahat. Masters thesis, Universiti Teknologi MARA.
repository_type Digital Repository
institution_category Local University
institution Universiti Teknologi MARA
building UiTM Institutional Repository
collection Online Access
language English
topic RM Therapeutics. Pharmacology
Immunotherapy. Serotherapy
spellingShingle RM Therapeutics. Pharmacology
Immunotherapy. Serotherapy
Jumahat, Noor Masyitah
Identification and immunogenicity study of soluble protein derived from pasteurella multocida serotype B / Noor Masyitah Jumahat
description Pasteurella multocida (P. multocida) serotype B is associated with hemorrhagic septicaemia (HS) disease endemic in Africa, India and Asian countries. It is causative agent of thriftily significant disease in livestock. Hence, this study purposed and aimed to identify and express an immunogenic soluble protein of P. multocida in efforts toward development of HS vaccine. Immunogenic soluble protein was identified as lipoprotein B (plpB) using electrospray mass spectrometry. The size of expressed purified recombinant protein was approximately 39kDa. Immunogenicity study of the recombinant protein plpB was carried out using 6 groups o f BALB/c mice. The groups were immunized with recombinant protein (Group 1), soluble recombinant protein (Group 2), insoluble recombinant protein (Group 3), vector (Group 4), soluble protein o f P. multocida (Group 5) and PBS (Group 6 ) respectively. Mice in group 4 and 6 showed signs and symptom of HS after challenge with the parental strain (p-value < 0.05). However, immunised mice with purified recombinant protein did not show signs and symptoms of HS. Based on immunoblotting analysis, purified recombinant protein was significantly immunogenic (p-value < 0.05). Additionally, no inflammation was seen in the tissues o f organs from mice immunized with purified recombinant protein, which indicates that recombinant protein was 100% protective towards P. multocida infection and eventually towards HS disease. Thus, this study shows that the recombinant protein lipoprotein B (plpB) is significantly immunogenic and could be a potential candidate in developing vaccine against HS.
format Thesis
author Jumahat, Noor Masyitah
author_facet Jumahat, Noor Masyitah
author_sort Jumahat, Noor Masyitah
title Identification and immunogenicity study of soluble protein derived from pasteurella multocida serotype B / Noor Masyitah Jumahat
title_short Identification and immunogenicity study of soluble protein derived from pasteurella multocida serotype B / Noor Masyitah Jumahat
title_full Identification and immunogenicity study of soluble protein derived from pasteurella multocida serotype B / Noor Masyitah Jumahat
title_fullStr Identification and immunogenicity study of soluble protein derived from pasteurella multocida serotype B / Noor Masyitah Jumahat
title_full_unstemmed Identification and immunogenicity study of soluble protein derived from pasteurella multocida serotype B / Noor Masyitah Jumahat
title_sort identification and immunogenicity study of soluble protein derived from pasteurella multocida serotype b / noor masyitah jumahat
publishDate 2015
url http://ir.uitm.edu.my/id/eprint/27214/
http://ir.uitm.edu.my/id/eprint/27214/1/TM_NOOR%20MASYITAH%20JUMAHAT%20MD%2015_5.pdf
first_indexed 2023-09-18T23:18:01Z
last_indexed 2023-09-18T23:18:01Z
_version_ 1777419242999644160